6505--Pylarify - Radiopharmaceutical Sole Source Award
Award Notice Posted
- Solicitation number
- 36C24426AP0412
- Agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Awarded
- to Progenics Pharmaceuticals Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36F79725D009336C24426F0056 Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a sole source contract to Progenics Pharmaceuticals Inc. for $433,046.40 on November 12, 2025, to procure Pylarify (piflutfolastat F-18) Injection, a radioactive diagnostic radiopharmaceutical used for positron emission tomography imaging of prostate-specific membrane antigen positive lesions in men with prostate cancer. The contract covers 120 units of the product and includes a base year running from January 1, 2026 through December 31, 2026, with an optional second year from January 1, 2027 through December 31, 2027. The sole source designation was justified by Progenics Pharmaceuticals' exclusive distribution and marketing rights for this FDA-approved product, which has a short half-life of only a few hours. The contract was issued under the Multiple-Award Schedule Program with the Network Contracting Office in Wilkes-Barre, Pennsylvania.
Notice text
Awarded contract 36F79725D009336C24426F0056 to PROGENICS PHARMACEUTICALS INC for 433046.40 on 2025-11-12.
Files
| File | Type | Posted |
|---|---|---|
| P03_LSJ-Pylarify_HCA_Redacted.pdf | ||
| 36F79725D0093 36C24426F0056_1.docx | DOCX document |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity